‘145 cases of JN.1 variant reported till December 28’

The emergence of the JN.1 variant, with its unique genetic makeup, has raised concerns among public health experts due to its association with severe pneumonia. Researchers are investigating the specific genetic markers and mutations of JN.1 that contribute to its enhanced ability to induce pneumonia. Preliminary findings suggest that alterations in the virus’s spike protein and other key components may facilitate a more efficient invasion of lung cells, leading to a heightened inflammatory response. Vigilance, vaccination, and collaboration are crucial in addressing the challenges posed by the JN.1 variant.